Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary supplement inactive listing

This article was originally published in The Tan Sheet

Executive Summary

Supplement makers' use of the phrase "may contain" or "may also contain" to list ingredients that may or may not appear in the product when manufactured by multiple suppliers is requested in a citizen petition submitted to FDA June 2 by law firm Arnall Golden & Gregory on behalf of an unnamed client. The client, a supplement manufacturer, also packages "thousands" of supplements for "hundreds" of retailers, and is likely the same company that recently made an identical request for varying inactive ingredient listing on OTC labeling of drugs sourced by different suppliers (1"The Tan Sheet" June 5, p. 4). The supplement petition does not apply to dietary ingredients, which must be listed precisely under the FD&C Act

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091299

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel